Matrubials Inc. is developing novel antibacterial therapeutics to address non-selectivity and emerging antimicrobial resistance. The company's mission is to provide safe solutions that can reduce the healthcare and economic burden resulting from bacterial infections and concomitant clinical complications. Its first indication is Bacterial Vaginosis (BV), which impacts almost a third of all women. ...